旗天科技(300061.SZ)孫公司擬向邦道信息提供代充值服務平台技術支撐服務以及其他市場營銷活動的服務支撐
格隆匯5月15日丨旗天科技(300061.SZ)公佈,根據經營及業務發展需要,公司孫公司南京飛翰信息技術有限公司(“飛翰”)擬與關聯方上海邦道信息技術有限公司(“邦道信息”)簽署日常關聯交易協議,飛翰向其提供代充值服務平台技術支撐服務以及其他市場營銷活動的服務支撐。
此次關聯交易事項屬於正常的商業交易行為,遵循市場公允原則,不存在損害公司和股東利益的情況。此次關聯交易事項將會擴大公司市場份額,增加公司收入和利潤來源,但不會對公司的財務狀況、經營成果及獨立性構成重大影響,公司主營業務不會因此次關聯交易而對關聯人形成依賴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.